May 15, 2026 06:42AM
Mar 30, 2026 09:27AM
Feb 5, 2026 08:05AM
Jan 7, 2026 06:32AM
Nov 4, 2025 08:00AM
Jun 10, 2025 06:08AM
May 21, 2025 09:11AM Alumis (ALMS) Completes Merger with ACELYRIN
May 21, 2025 09:10AM
May 13, 2025 01:00PM
May 13, 2025 01:00PM
May 6, 2025 04:30PM
Apr 21, 2025 06:36AM
Apr 21, 2025 06:30AM
Mar 4, 2025 09:05AM Alumis (ALMS) and ACELYRIN (SLRN) Reaffirm Strategic and Financial Rationale of Proposed Merger
Mar 4, 2025 09:01AM
Mar 4, 2025 09:01AM
Mar 4, 2025 09:00AM
Feb 21, 2025 07:21AM
Feb 20, 2025 09:00PM
Feb 6, 2025 04:16PM
Feb 6, 2025 04:15PM Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Nov 4, 2024 08:00AM
Jun 28, 2024 05:50AM
Jun 27, 2024 11:57PM
Jun 18, 2024 06:08AM

22,935 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All